| Business

Become a contributor

Bookmark Econotimes

| Business

Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit

OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering

AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock

Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate

Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies

Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains

Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch

Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026

Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised

Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate

Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks

TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment

SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates

Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies

Instagram Outage Disrupts Thousands of U.S. Users

Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile

Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil

©Econometrics LLC . All Rights Reserved.

Nasdaq Halts Kitov Pharmaceuticals Holdings Ltd.

Tuesday, February 7, 2017 3:08 PM UTC

NEW YORK, Feb. 07, 2017 -- The Nasdaq Stock Market^® (Nasdaq:NDAQ) announced that trading was halted today in Kitov Pharmaceuticals Holdings Ltd. (Nasdaq:KTOV), (Nasdaq:KTOVW) at 09:22:28 Eastern Time for "additional information requested" from the company at a last sale price of $2.55 and $0.89 respectively.

Trading will remain halted until Kitov Pharmaceuticals Holdings Ltd. has fully satisfied Nasdaq’s request for additional information.

For news and additional information about the company, please contact the company directly or check under the company’s symbol using InfoQuotes^SMon the Nasdaq^® Web site.

For more information about The Nasdaq Stock Market, visit the Nasdaq Web site at http://www.nasdaq.com.

NDAQO

Nasdaq Media Contact:
Peter Gau
+1.212.231.5475
[email protected]

Editor's Picks

Breathing through your nose when you exercise may make your runs easier

Entrepreneurs are facing a mental health crisis — here's how to help them

Are fish oil supplements as healthy as we think? And is eating fish better?

Will AI kill our creativity? It could – if we don’t start to value and protect the traits that make us human

Does AI have a right to free speech? Only if it supports our right to free thought

How can I lower my cholesterol? Do supplements work? How about psyllium or probiotics?

Why we need to set limits on sperm donation

Aging with a healthy brain: How lifestyle changes could help prevent up to 40% of dementia cases

Seven techniques to avoid weight regain, approved by experts

Market Data

Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge

Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate

Trump Says “Very Good Talks” Underway on Russia-Ukraine War as Peace Efforts Continue

Trump Signs Executive Order Threatening 25% Tariffs on Countries Trading With Iran

New York Legalizes Medical Aid in Dying for Terminally Ill Patients

China Extends Gold Buying Streak as Reserves Surge Despite Volatile Prices

FxWirePro: GBP/NZD downtrend accelerates, vulnerable to more down side

Dow Hits 50,000 as U.S. Stocks Stage Strong Rebound Amid AI Volatility

SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates

EconoTimes

Disclaimer: EconoTimes provides references and links to selected blogs and other sources of economic and market information as an educational service to its clients and prospects and does not endorse the opinions or recommendations of the blogs or other sources of information. Clients and prospects are advised to carefully consider the opinions and analysis offered in the blogs or other information sources in the context of the client or prospect's individual analysis and decision making. None of the blogs or other sources of information is to be considered as constituting a track record. Past performance is no guarantee of future results and EconoTimes specifically advises clients and prospects to carefully review all claims and representations made by advisors, bloggers, money managers and system vendors before investing any funds or opening an account with any Brokerage. Any news, opinions, research, data, or other information contained within this website is provided as general market commentary and does not constitute investment or trading advice. EconoTimes expressly disclaims any liability for any lost principal or profits without limitation which may arise directly or indirectly from the use of or reliance on such information. As with all such advisory services, past results are never a guarantee of future results.

Nasdaq Halts Kitov Pharmaceuticals Holdings Ltd.

Editor's Picks

Welcome to EconoTimes